International Journal of Gynecology & Obstetrics最新文献

{"title":"The risk factors and prognostic impact of different benign pathologic types of background endometrium surrounding endometrial polyps.","authors":"Jiezhuang Huang, Yuxin Li, Peiyue Chen, Zhifu Zhi","doi":"10.1002/ijgo.16067","DOIUrl":"https://doi.org/10.1002/ijgo.16067","url":null,"abstract":"<p><strong>Objective: </strong>This retrospective study investigated the prognostic significance and risk factors of benign pathologic types of background endometrium surrounding endometrial polyps (EPs).</p><p><strong>Methods: </strong>We assessed 206 patients who underwent hysteroscopic polypectomy and background endometrium biopsy. Patients were categorized into four groups based on the pathologic types of background endometrium: normal proliferative endometrium (NPE), polypoid hyperplastic endometrium (PHE), chronic endometritis (CE), and non-atypical endometrial hyperplasia (NEH). We employed univariable comparisons and multivariable logistic regression analysis to identify risk factors of PHE, CE, and NEH compared to NPE. Abnormal uterine bleeding (AUB) and recurrence of EPs were monitored over a 12-month postoperative follow-up period.</p><p><strong>Results: </strong>Independent risk factors for EPs with a background of CE included a history of genital tract infection (OR = 8.88, 95% CI: 2.95-26.70, P = 0.000), adenomyosis (OR = 13.70, 95% CI: 3.38-55.52, P = 0.000), and hydrosalpinx (OR = 2.23, 95% CI: 1.59-54.09, P = 0.013). Age (OR = 1.18, 95% CI: 1.07-1.30, P = 0.001) and BMI (OR = 1.33, 95% CI: 1.11-1.61, P = 0.003) were significant risk factors for EPs with a background of NEH. Patients with PHE had higher recurrence rates of EPs following 12 months of follow-up. Moreover, background endometrium types PHE, CE, and NEH were associated with poorer control of AUB.</p><p><strong>Conclusion: </strong>Our study underscores the importance of examining the histopathologic characteristics of the background endometrium surrounding EPs, as these benign lesions significantly influence the recurrence and symptomatology of EPs.</p>","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142750806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Gynecology and obstetrics patients' attitudes towards body privacy: A cross-sectional-descriptive study.","authors":"Rana Can Özdemir, Meryem Türkan Işık, Hüseyin Durukan","doi":"10.1002/ijgo.16070","DOIUrl":"https://doi.org/10.1002/ijgo.16070","url":null,"abstract":"<p><strong>Objective: </strong>It is extremely important for healthcare professionals to protect patients' privacy during diagnosis and treatment processes related to gynecology and obstetrics and to warn them in case patients' privacy is violated. This study was aimed at determining attitudes of female patients having obstetrics examination towards privacy and raising their awareness of privacy.</p><p><strong>Methods: </strong>This cross-sectional-descriptive study was conducted with 410 patients who presented to the gynecology and obstetrics outpatient clinic of a university hospital. The survey form consisted of two forms: The descriptive characteristics questionnaire and the body privacy scale for gynecology and obstetrics (BPSGO). Frequency tables, descriptive statistics, Mann-Whitney U-test, Kruskal-Wallis H-test, and Bonferroni correction were used in the analysis of the data.</p><p><strong>Results: </strong>The mean age of the participants was 36.75 ± 11.18 years. Of these, 38.0% were in the age group of ≥40 years, 84.0% were married, 66.8% presented to the gynecology clinic, and 58.3% had negative emotions before they had gynecologic examination. Ethics and privacy subscale scores of the single participants were significantly higher than were those of the married participants.</p><p><strong>Conclusion: </strong>It was determined that privacy was affected by cultural characteristics, belief systems and personal values, and that most of the participants were likely to experience negative emotions. It is important to raise health professionals' awareness of privacy by drawing their attention to the value of privacy which is among ethical values in their education and to support the better functioning of legal regulations on this issue.</p>","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142750768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Remote blood pressure monitoring in women at risk of or with hypertensive disorders of pregnancy: A systematic review and meta-analysis.","authors":"Theepika Rajkumar, Annemarie Hennessy, Angela Makris","doi":"10.1002/ijgo.16059","DOIUrl":"https://doi.org/10.1002/ijgo.16059","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Remote blood pressure monitoring refers to an organized framework that either allows clinicians to review home-based blood pressure readings and institute management, or provide participants with clear instructions for contacting care teams when blood pressure readings are out of prespecified targets. With widespread uptake of telemonitoring and mobile health in recent years, such models of care have been increasingly described in the literature.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;This study aimed to review remote blood pressure monitoring in pregnant and postpartum women who are at high-risk for or have an established diagnosis of hypertensive disorders of pregnancy, and its effect on maternal and fetal outcomes, healthcare utilization and psychosocial outcomes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Search strategy: &lt;/strong&gt;PubMed, Medline, Embase, Cochrane Library, Web of Science and CINAHL databases were searched electronically in June 2024 to their inception.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study selection criteria: &lt;/strong&gt;Included studies compared remote blood pressure monitoring with standard care. Remote blood pressure monitoring was pre-defined as any framework for measuring blood pressure remotely in pregnancy, with organized review by clinicians. Published full-text and study abstracts describing randomized controlled trials and observational studies were included. The study population was pregnant women at high-risk for developing pre-eclampsia or postpartum (&lt;6 weeks) women with an established diagnosis of a hypertensive disorder of pregnancy. Remote blood pressure monitoring undertaken in the antenatal and postnatal periods were analyzed separately.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Data collection and analysis: &lt;/strong&gt;This systematic review was conducted according to the Preferred Reporting Item for Systematic Reviews and Meta-Analyses statement. Screening of records and data extraction were independently performed. Data were extracted and analyzed using Review Manager software (version 5.4; Cochrane Collaboration, Copenhagen, Denmark). Risk of bias and quality assessment was performed independently using the Risk Of Bias In Non-randomized Studies-of Interventions (ROBINS-I) assessment tool and the Cochrane Risk of Bias 2 (RoB2) tool.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main results: &lt;/strong&gt;A total of 18 studies with 28 094 patients were included. Antenatal remote blood pressure monitoring reduces antenatal outpatient visits, antenatal hospital admissions for any cause, and antenatal hospital admissions specifically for hypertension. Importantly, there was no increase in adverse maternal and fetal outcomes, including the likelihood of cesarean section deliveries or induction of labor due to hypertension, composite maternal outcome, growth restriction, neonatal intensive care unit admissions, gestational age at delivery and the composite fetal outcome. Psychosocial outcomes were also not significantly different between the remote blood pressure monitoring and usual care groups.","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142750802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Depression and quality of life among ever pregnant versus never pregnant adolescent girls and young women in western Kenya.","authors":"Winnie Kavulani Luseno, Bonita J Iritani, Frederick Sifunjo Odongo","doi":"10.1002/ijgo.16064","DOIUrl":"https://doi.org/10.1002/ijgo.16064","url":null,"abstract":"","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142739321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparing the coagulation and platelet parameters of women with premature ovarian insufficiency with those of age-matched controls: A case-control study.","authors":"Zheng Lou, Yizhou Huang, Hongyan Xu, Xiaoping Cen, Yue Zhang, Yan Xu, Zhou Luo, Chunming Li, Caiwei Chen, Shuyi Shi, Chang Su, Xi Lin, Linjuan Ma, Jianhong Zhou","doi":"10.1002/ijgo.16042","DOIUrl":"https://doi.org/10.1002/ijgo.16042","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to compare the coagulation and platelet parameters in women with spontaneous premature ovarian insufficiency (POI) with those in age-matched controls.</p><p><strong>Methods: </strong>This case-control study recruited 202 women with POI and 202 age-matched women with benign gynecological diseases as controls. Coagulation parameters, including prothrombin time (PT), international normalized ratio (INR), activated partial thromboplastin time (APTT), and thrombin time (TT), fibrinogen, and platelet parameters, including platelet count (PLT), mean platelet volume (MPV), plateletcrit (PCT), and platelet distribution width (PDW), were compared between women with POI and controls. Factors associated with coagulation and platelet parameters were also analyzed in women with POI.</p><p><strong>Results: </strong>In women with POI, higher fibrinogen levels and PDW, lower PLT, MPV, and PCT levels, and shorter TT were observed (p < 0.001). Linear regression analysis further revealed that women with POI were more likely to exhibit increased serum fibrinogen levels (β = 0.465, 95% confidence interval [CI] 0.366-0.564) and PDW (β = 0.340, 95% CI 0.300-0.379), decreased TT (β = -1.101, 95% CI -1.233--0.969), PLT (β = -50.985, 95% CI -65.087--36.882), MPV (β = -1.498, 95% CI -1.875 to -1.120), PCT levels (β = -0.084, 95% CI -0.095--0.973). Additionally, follicle-stimulating hormone levels were positively associated with fibrinogen levels in women with POI. There were no statistically significant differences in PT, INR, and APTT between women with POI and controls.</p><p><strong>Conclusions: </strong>Women with POI exhibited decreased platelet numbers, abnormal platelet morphology, and elevated fibrinogen concentrations, potentially implicating POI's etiopathogenesis or contributing to an increased risk of cardiovascular disease in women with POI. No coagulation abnormalities were observed in women with POI.</p>","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142739319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Displacement and menstrual shame for adolescent girls in South Sudan's humanitarian crises: A cross-sectional analysis.","authors":"Ellen Spiller, Alexandra Blackwell, Cosmas Ayella, Kathryn Falb","doi":"10.1002/ijgo.16053","DOIUrl":"https://doi.org/10.1002/ijgo.16053","url":null,"abstract":"","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142739322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cost-effectiveness of a randomized controlled trial comparing low-dose aspirin to placebo for the prevention of recurrent preterm birth.","authors":"Anadeijda J E M C Landman, Hana M Broulikova, Laura Visser, Tobias A J Nijman, Marieke A C Hemels, Karin C Vollebregt, Elisabeth M A Boormans, Henk A Bremer, Esther Tuinman, Josje Langenveld, Flip van der Made, Robbert J P Rijnders, Huib A A M van Vliet, Liv M Freeman, Roel de Heus, Judith Blaauw, Ineke Krabbendam, Rafli van de Laar, Marieke F G Verberg, Hubertina C J Scheepers, Ben W Mol, Christianne J M de Groot, Martijn A Oudijk, Judith E Bosmans, Marjon A de Boer","doi":"10.1002/ijgo.16024","DOIUrl":"https://doi.org/10.1002/ijgo.16024","url":null,"abstract":"<p><p>To assess the cost-effectiveness of low-dose aspirin compared to placebo for the prevention of recurrent preterm birth from a healthcare perspective. This was a cost-effectiveness analysis alongside a multicenter, randomized, double-blinded, placebo-controlled trial. We included women with a singleton pregnancy and a previous spontaneous preterm birth <37 weeks of gestation of a singleton. Women were randomized between aspirin 80 mg daily and placebo, initiated between 8 and 16 weeks of gestation. We estimated the difference in preterm births (<37 weeks of gestation), and maternal and neonatal healthcare costs using seemingly unrelated linear regression analyses. Bootstrapping was performed to estimate statistical uncertainty. A total of 387 women were included: 194 in the aspirin group and 193 in the placebo group. We observed a small, statistically non-significant difference in preterm birth (21.2% vs. 25.4%; risk difference -4.3%; 95% CI: -12.7% to 4.1%) and healthcare costs (mean -€99; 95% CI: -€2385 to €2325) in the aspirin group compared to placebo. The cost-effectiveness acceptability curve showed that the probability of aspirin being cost-effective was 54% for a willingness to pay threshold of €0 for one prevented preterm birth and 78% for €50 000 for one prevented preterm birth. Our findings suggest that aspirin is the dominant strategy over placebo for the prevention of preterm birth. However, there was substantial uncertainty around the results and definite conclusions regarding the cost-effectiveness of aspirin cannot be drawn.</p>","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142739320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevention of maternal mortality with interventions in primary care services: What can we do?","authors":"Jussara Mayrink, Maria L Costa, Renato T Souza, Lucas T C Sampaio, Jose G Cecatti","doi":"10.1002/ijgo.16052","DOIUrl":"https://doi.org/10.1002/ijgo.16052","url":null,"abstract":"<p><p>Despite global progress and a marked reduction in maternal mortality ratio worldwide, the burden of maternal death and morbidity remains a huge challenge, especially among low- and middle-income settings. Maternal mortality is determined by multiple components. As a result, sustainable strategies require not only the implementation of effective health policies but also social development. In this narrative review, we discuss strategies to improve the maternal mortality ratio based on recent advances in public health. Primary care plays a key role in identifying background conditions, risk factors and early signs of some major causes of maternal mortality and morbidity. Antenatal care also addresses other conditions that influence outcomes: unwanted pregnancies, nutrition, sexually transmitted illnesses, family planning, immunization, and child health. Therefore, awareness about major causes of maternal mortality, direct and indirect targeted interventions to adequately identify risk factors, implement prophylactic interventions when available and guarantee early diagnosis, can certainly impact outcomes.</p>","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142728796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Risk factors for ectopic pregnancy occurrence: Systematic review and meta-analysis.","authors":"Ana Carolina Sarmento Brim, Victor Rivera Duran Barretto, José Guilherme Reis-Oliveira, Renata Balthazar da Silveira de Araújo, Ana Célia Diniz Cabral Barbosa Romeo","doi":"10.1002/ijgo.15965","DOIUrl":"https://doi.org/10.1002/ijgo.15965","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Given the high incidence of ectopic pregnancy (EP) in the general population and the high maternal morbidity and mortality rates associated with it, determining risk factors for the occurrence of EP is essential for directing attention and care to risk groups, aiming for early diagnosis, favorable outcomes, and the development of prevention strategies.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;The aim of this study was to identify risk factors for the occurrence of EP.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Search strategy: &lt;/strong&gt;A systematic review with meta-analysis was performed on the electronic databases MEDLINE/PubMed, LILACS, The Cochrane Library, and Virtual Health Library (VHL), searching the following terms \"Ectopic Pregnancy\" or \"Ectopic Gestation\" and \"Risk Factors\" or \"Predisposing Factors\".&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Selection criteria: &lt;/strong&gt;The inclusion criteria were observational studies published in English and Portuguese. We excluded studies with undefined methodology and those published before the year 2000.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Data collection and analysis: &lt;/strong&gt;The authors independently read the titles, abstracts, and full texts, using pre-defined inclusion and exclusion criteria, and discussed any differences. Data extraction and assessment of methodological quality were performed by each author in a standardized way. Sixteen risk factors were evaluated. The meta-analysis calculations were performed using the Reviewer Manager 5.3 software (RevMan 5.3).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main results: &lt;/strong&gt;The study found 715 studies, of which 11 were selected for review. The surveys were conducted between 2003 and 2019 and included 25 051 patients. The study revealed that several factors were strongly associated with the occurrence of EP. These included EP history (OR 9.03; 95% CI: 7.18-11.35; I&lt;sup&gt;2&lt;/sup&gt; = 67%), pelvic inflammatory disease (OR 4.00; 95% CI: 3.46-4.61; I&lt;sup&gt;2&lt;/sup&gt; = 0%), infertility (OR 3.70; 95% CI: 3.23-4.23; I&lt;sup&gt;2&lt;/sup&gt; = 48%), abdominal and pelvic surgeries (OR 5.60; 95% CI: 4.83-6.49; I&lt;sup&gt;2&lt;/sup&gt; = 81%), and previous tubal ligation (OR 5.59; 95% CI: 2.49-12.55; I&lt;sup&gt;2&lt;/sup&gt; = 0%). Furthermore, the study showed that advanced maternal age, smoking, number of partners exceeding one, history of spontaneous and induced abortion, previous use of emergency contraception, and intrauterine device, demonstrated a slightly increased risk. Advanced maternal age within the range of 30-34 years (OR 1.13; 95% CI: 1.03-1.24; I&lt;sup&gt;1&lt;/sup&gt; = 11%) and ≥ 40 years (OR 1.46; 95% CI: 1.19-1.78; I&lt;sup&gt;1&lt;/sup&gt; = 88%), marital status (OR 1.19; 95% CI: 1.03-1.37; I&lt;sup&gt;2&lt;/sup&gt; = 88%), and the use of oral contraceptives (OR 0.77; 95% CI: 0.66-0.90; I&lt;sup&gt;2&lt;/sup&gt; = 86%) were also found to be associated with a slightly increased or decreased risk of EP, respectively. The impact of condom use on the occurrence of EP seems to be very limited (OR 0.93; 95% CI: 0.83-1.05; I&lt;sup&gt;2&lt;/sup&gt; = 83%).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Based on the study find","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142728797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Obstetrics and gynecology devices designed for low- and middle-income countries: A narrative review.","authors":"Dhanalakshmi Thiyagarajan, Enaam A Adanu, K Rivet Amico","doi":"10.1002/ijgo.16048","DOIUrl":"https://doi.org/10.1002/ijgo.16048","url":null,"abstract":"<p><p>There are many barriers contributing to poor health outcomes for women in low- and middle-income countries (LMICs), one of which is the lack of necessary medical devices. Presently, the development of various kinds of devices intended to improve women's health outcomes specifically in LMICs remains underrepresented in the literature; therefore, we performed a narrative review to understand this current state of literature. A literature search was conducted in Scopus and Overton between December 2023 to February 2024, and PubMed in October 2024 to broadly explore peer-reviewed publications focusing on understanding the development of devices used specifically in obstetrics and gynecology (OBGYN) care in LMICs. The initial search identified 132 published manuscripts: 114 non-duplicates from 1993 to 2024. After a two-research team member independent review, 22 manuscripts from 2011 to 2023 were included, and 18 devices identified. Nine devices focus on postpartum hemorrhage, four on general obstetrics, one on fetal monitoring, one on vaginal deliveries, one on gynecology hemorrhage, one on gynecology screening, and one on OBGYN anesthesia. This review provides recommendations for areas of improvement of key gaps affecting the development and implementation of OBGYN devices for use in LMICs. Recommendations are provided for various stages of the development to early commercialization phases. We believe future incorporation of these recommendations can aid in equitable and implementable medical device design for OBGYN care in LMICs.</p>","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142716093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}